A comparative study of IgG second- and third-generation anti-cyclic citrullinated peptide (CCP) ELISAs and their combination with IgA third-generation CCP ELISA for the diagnosis of rheumatoid arthritis

Clinical Rheumatology

Volumn 28, Issue 2, 2009, Pages 153-158

  Enriconi dos Anjos, Lisiane Maria ^a   Pereira, Ivanio Alves ^b   d 'Orsi, Eleonora ^b   Seaman, Andrea Piette ^c   Burlingame, Rufus Watson ^c   Morato, Edelton Flavio ^b  

^a UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^c INOVA DIAGNOSTICS INC   (United States)

Author keywords

Anti CCP antibodies; Clinical laboratory techniques; Cyclic citrullinated peptide; Rheumatoid arthritis

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MAXIMUM LIKELIHOOD METHOD; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; ANTIBODIES, ANTI-IDIOTYPIC; ARTHRITIS, RHEUMATOID; BRAZIL; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; PREDICTIVE VALUE OF TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 58149199792     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-008-0999-5     Document Type: Article

References (41)

1. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines (1996) Guideline arthritis. Arthritis Rheum 39:713-722
2. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines (2002) Guideline arthritis: 2002 Update. Arthritis Rheum 46:328-346
3. van Boekel MAM, Vossenaar ER, van den Hoogent FHJ, Venrooij WJ (2002) Autoantibody systems in rheumatoid arthritis: Specificity, sensitivity and diagnostic value. Arthritis Res 4:87-93
4. Steiner G, Smolen J (2002) Autoantibodies in rheumatoid arthritis and their clinical significance. Arthritis Res 4:S1-S5
5. Mageed RA (1996) The RF antigen. In: Van Venrooij WJ, Maini RN (eds) Manual of Biological Markers of Disease. Kluwer Academic, Dordrecht, B1.1, pp 1-27
6. Nienhuis RLF, Mandena EA (1964) A new serum factor in patients with rheumatoid arthritis. The antiperinuclear factor. Ann Rheum Dis 23:302-305
7. Johnson GD, Carvalho A, Holborow EJ, Goddard DH, Russell G (1981) Antiperinuclear factor and keratin antibodies in rheumatoid arthritis. Ann Rheum Dis 40:263-266
8. Hoet RM, Van Venrooij WJ (1992) The antiperinuclear factor and antikeratin antibodies in rheumatoid arthritis. In: Smolen J, Kalden J, Maini RN (eds) Rheumatoid arthritis. Springer, Berlin, pp 299-318
9. Young BJJ, Mallya RK, Leslie RDG, Clark CJM, Hamblin TJ (1979) Anti-keratin antibodies in rheumatoid arthritis. Br Med J 2:97-99
10. Sebbag M, Simon M, Vincent C, Masson-Bessiere C, Girbal E, Duri JJ (1995) The antiperinuclear factor and the so-called antikeratin are the same rheumatoid arthritis-specific autoantibodies. J Clin Invest 95:2672-2679
11. Vincent C, Simon M, Sebbag M, Girlbal-Neuhauser E, Durieux JJ, Cantagrel A, Fournie B, Mazieres B, Serre G (1998) Immunoblotting detection of autoantibodies to human epidermis filaggrin: A new diagnostic test for rheumatoid arthritis. J Rheumatol 25:838-846
12. Serre G (2001) Autoantibodies to filaggrin/deiminated fibrin (AFA) are useful for the diagnosis and prognosis of rheumatoid arthritis, and are probably involved in the pathophysiology of the disease. Jt Bone Spine 68:103-105
13. Schellekens GA, de Jong BAW, van den Hoogen FHJ, van de Putte LBA (1998) Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 101:273-281
14. Girbal-Neuhauser E, Durieux J-J, Arnaud M, Dalbon P, Sebbag M, Vincent C, Simon M, Senshu T, Masson-Bessiere C, Jolivet- Reynaud C, Jolivet M, Serre G (1999) The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol 162:585-594
15. Lapointe E, Dery U, Vaillanciurt F, Menard HA (1999) Rheumatoid sera potentially recognize all citrullinated proteins. Arthritis Rheum 42:86
16. Vittecoq O, Incaurgarat B, Jouen-Beades F, Legoedec J, Letourneur O, Rolland D, Gervasi G, Menard JF, Gayet A, Fardellone P, Daragon A, Jolivet M, Ie Loet X, Tron F (2004) Autoantibodies recognizing citrullinated rat filaggrin in an ELISA using citrullinated and non-citrullinated recombinant proteins as antigens are highly diagnostic for rheumatoid arthritis. Clin Exp Immunol 135:173-180
17. Schellekens GA, Visser H, de Jong BAW, Van Den Hoogen FHJ, Hazes JMW, Breedveld FC, Van Venrooij WJ (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43:155-163
18. Van Gaalen FA, Visser H, Huizinga TW (2005) A comparison of the diagnostic accuracy and prognostic value of the first and second anti-cyclic citrullinated peptides (CCP1 and CCP2) autoantibody tests for rheumatoid arthritis. Ann Rheum Dis 64:1510-1512
19. Saraux A, Berthelot JM, Devauchelle V, Bendaoud B, Chalès G, Le Henaff C, Thorel JB, Hoang S, Jousse S, Baron D, Le Goff P, Youinou P (2004) Value of antibodies to citrulline-containing peptides for diagnosing early rheumatoid arthritis. J Rheumatol 30:2535-2539
20. Sauerland U, Becker H, Seide M, Schotte H, Willeke P, Schorat A, Schluter B, Domschke W, Gaubitz M (2005) Clinical utility of the anti-CCP assay: Experiences with 700 patients. Ann NY Acad Sci 1050:314-318
21. Vallbracht I, Rieber J, Oppermann M, Forger F, Siebert U, Helmke K (2004) Diagnostic and clinical value of anti-cyclic citrulinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Ann Rheum Dis 63:1079-1084
22. Dubrous P, Gardet V, Hugard L (2005) Value of anti-cyclic citrullinated peptides antibodies in comparison with rheumatoid factor for rheumatoid arthritis diagnosis. Pathol Biol 53:63-67
23. Silveira IG, Burlingame RW, von Mühlen CA, Bender AL, Staub HL (2007) Anti-CCP antibodies have more diagnostic impact than rheumatoid factor (RF) in a population tested for RF. Clin Rheumatol 26:1883-1889
24. Vallbracht I, Helmke K (2005) Additional diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Autoimmun Rev 4:389-394
25. Solanki K, Spellerberg M, Chapman P, Moller P, O'Donnell J (2004) Anti-cyclic citrullinated antibodies: Complementary to IgM rheumatoid factor in the early diagnosis of rheumatoid arthritis. N Z Med J 117:1097
26. Araki C, Hayashi N, Moriyama M, Morinobu S, Mukai M, Koshiba M, Kawano S, Kumagai S (2004) Usefulness of anti-cyclic citrullinated peptide antibodies (anti-CCP) for the diagnosis of rheumatoid arthritis. Rinsho Byori 52:966-972
27. Avouac J, Gossec L, Dougados M (2006) Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: A systematic literature review. Ann Rheum Dis 65:845-851
28. Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S, Saigo K, Morinobu A, Koshiba M, Kuntz KM, Kamae I, Kumagai S (2007) Meta-analysis: Diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 146:797-808
29. Girelli F, Foscbi FG, Bedescbi E, Calderoni V, Stefanini GF, Martinelli MG (2004) Is Anti Cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis? Allerg Immunol 36:127-130
30. Berglin E, Padyukov L, Sundin U, Hallmans G, Stenlund H, van Venrooij WJ, Klareskog L, Dahlqvist SR (2004) A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis. Arthritis Res Ther 6:R303-R308
31. Nielen MJ, van Shaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinima IE, Dekoning MHMT, Habibuw MR, Vandenbroucke JP, Dijkmans BAC (2004) Specific autoantibodies precede the symptoms of Rheumatoid Arthritis. Arthritis Rheum 50:380-386
32. Van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, de Jong BA, Breedveld FC, Verweij CC, Toes REM, Huizinga TWJ (2004) Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: A prospective cohort study. Arthritis Rheum 50:709-715
33. Rormelid J, Wick MC, Lampa J, Lindblad S, Nordmark B, Klareskog L, van Vollenhoven RF (2005) Longitudinal analysis of citrullinated protein/ peptide antibodies (anti-CCP) during 5 year follow up in early rheumatoid arthritis: Anti-CP status predicts worse disease activity and greater radiological progression. Ann Rheum Dis 64:1744-1749
34. De Rycke L, Peene I, De Keyser F (2004) Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: Diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann Rheum Dis 63:1587-1593
35. van Jaarsveld CD, ter Borg EJ, Jacobs JW, Schellekens GA, Gmelig-Meyling FH, van Booma-Frankfort C, de Jong BA, van Venrooij WJ, Bijlsma JW (1999) The prognostic value of the antiperinuclear factor, anticitrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis. Clin Exp Rheumatol 17:689-697
36. Verpoort KN, Jol-van der Zijde CM, Papendrecht-van der Voort EA, Ioan-Facsinay A, Drijfhout JW, van Tol MJ, Breedveld FC, Huizinga TW, Toes RE (2006) Isotype distribution of anti-cyclic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response. Arthritis Rheum 54:3799-3808
37. Santiago M, Baron M, Miyachi K, Fritzler MJ, Abu-Hakima M, Leclercq S, Bell M, Hudson M, Mathieu JP, Taillefer S, Jones N, Docherty P, Khraishi M, Markland J, Pope J, Robinson D, Smith D, Sutton E (2008) A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis. Clin Rheumatol 27:77-83
38. Wu R, Shovman O, Zhang Y, Gilburd B, Zandman-Goddard G, Shoenfeld Y (2007) Increased prevalence of anti-third generation cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis and CREST syndrome. Clin Rev Allergy Immunol 32:47-56
39. American College of Rheumatology (1997) Revised Criteria for the Classification of Systemic Lupus Erythematosus. Arthritis Rheum 40:1725
40. Classification Criteria of Rheumatoid Arthrites, 1987. www.rheumatology.org/publications/classification/ra/1987 (accessed Dec 2007)
41. Martinez JB, Valero JS, Bautista AJ, Restrepo JF, Matteson EL, Rondon F, Iglesias-Gamarra A (2007) Erosive arthropathy: Clinical variance in lupus erythematosus and association with anti-CCP case series and review of the literature. Clin Exp Rheumatol 25:47-53